Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.88
-0.17-5.57%
At close: Dec 16, 4:00 PM EST
$2.97
0.093.13%
After Hours: 9:27 AM EST
Comments
Loading...
Q32 Bio Analyst Ratings and Price Targets | NASDAQ:QTTB | Benzinga
Q32 Bio Inc has a consensus price target of $24 based on the ratings of 8 analysts. The high is $95 issued by Wells Fargo on September 11, 2024. The low is $3 issued by BMO Capital on February 11, 2025. The 3 most-recent analyst ratings were released by Wells Fargo, BMO Capital, and Piper Sandler on March 12, 2025, February 11, 2025, and February 11, 2025, respectively. With an average price target of $7.33 between Wells Fargo, BMO Capital, and Piper Sandler, there's an implied 146.91% upside for Q32 Bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
BMO Capital
Piper Sandler
Oppenheimer
Leerink Partners
1calculated from analyst ratings
Analyst Ratings for Q32 Bio
FAQ
What is the target price for Q32 Bio (QTTB) stock?
The latest price target for Q32 Bio (NASDAQ:QTTB) was reported by Wells Fargo on March 12, 2025. The analyst firm set a price target for $15.00 expecting QTTB to rise to within 12 months (a possible 405.05% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Q32 Bio (QTTB)?
The latest analyst rating for Q32 Bio (NASDAQ:QTTB) was provided by Wells Fargo, and Q32 Bio maintained their equal-weight rating.
When was the last upgrade for Q32 Bio (QTTB)?
There is no last upgrade for Q32 Bio
When was the last downgrade for Q32 Bio (QTTB)?
The last downgrade for Q32 Bio Inc happened on February 11, 2025 when BMO Capital changed their price target from $22 to $3 for Q32 Bio Inc.
When is the next analyst rating going to be posted or updated for Q32 Bio (QTTB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Q32 Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Q32 Bio was filed on March 12, 2025 so you should expect the next rating to be made available sometime around March 12, 2026.
Is the Analyst Rating Q32 Bio (QTTB) correct?
While ratings are subjective and will change, the latest Q32 Bio (QTTB) rating was a maintained with a price target of $16.00 to $15.00. The current price Q32 Bio (QTTB) is trading at is $2.97, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
